SBIR Phase II: mid-market Innovation Research Development Grant 2026
Building upon validated feasibility concepts, Phase II represents the intensive engineering and development stage where promising innovations mature into functional prototype systems ready for rigorous field evaluation. This phase demands substantial investment in iterative hardware refinement, firmware optimization, user experience validation, and environmental stress testing that collectively determine whether a technology can withstand real-world deployment conditions. mid-market companies at this stage commonly undertake activities such as fabricating ruggedized enclosures for outdoor sensor networks, training deep learning classification models on domain-specific datasets, integrating payment processing middleware into fintech application stacks, or conducting biocompatibility assessments for implantable therapeutic devices. The extended funding timeline accommodates the nonlinear nature of genuine technical problem-solving, where unexpected material behavior, electromagnetic interference challenges, or algorithmic convergence difficulties require creative workarounds. Companies that successfully navigate Phase II emerge with demonstrable product-market validation, provisional patent portfolios, and customer testimonials that substantially de-risk subsequent private investment conversations. The extended development period also enables founders to establish manufacturing partnership agreements, secure component supply commitments, and complete regulatory pre-submission consultations that position their ventures for rapid commercialization acceleration upon securing Phase III or private follow-on capital.
Program Overview
SBIR Phase II is the development and demonstration phase, building on successful Phase I feasibility studies. Awards typically provide $750,000 over two years to develop prototypes, conduct R&D, and demonstrate commercial potential.
Funding Details
Standard Award: ~$750,000
Duration: 2 years typical
Note: Some agencies offer enhanced Phase II awards with higher funding levels or longer durations based on specific program needs.
Common Questions
Yes, SBIR Phase II funding is generally reserved for mid-market companies that have successfully completed a Phase I project and demonstrated promising results. The Phase II application builds on Phase I findings to propose a full research and development effort. Some agencies offer Direct-to-Phase-II options in limited circumstances, but the standard path requires Phase I completion first.
SBIR Phase II awards typically provide up to $1 million over a two-year period, though exact amounts vary by federal agency. Phase II supports the full research and development effort based on Phase I results. Some agencies offer Phase II Enhancement supplements that provide additional funding when matched by third-party investment, potentially increasing the total award significantly.
Successful applicants include detailed commercialization plans featuring identified customer segments, validated pricing structures, distribution channel partnerships, and realistic revenue forecasting models. Letters of intent from prospective purchasers and documented market validation through pilot deployments carry substantial weight. Agencies increasingly evaluate commercial potential alongside scientific merit, making business development preparation critical.
The Department of Defense typically offers larger Phase II budgets reaching USD 1.7 million with accelerated evaluation timelines around four months. The National Institutes of Health provides awards up to USD 1.5 million but employs longer peer-review cycles spanning six to nine months. The National Science Foundation emphasizes broader societal impact metrics and frequently requires supplemental educational outreach components.
Successful applicants include detailed commercialization plans featuring identified customer segments, validated pricing structures, distribution channel partnerships, and realistic revenue forecasting models. Letters of intent from prospective purchasers and documented market validation through pilot deployments carry substantial weight. Agencies increasingly evaluate commercial potential alongside scientific merit, making business development preparation critical.
The Department of Defense typically offers larger Phase II budgets reaching USD 1.7 million with accelerated evaluation timelines around four months. The National Institutes of Health provides awards up to USD 1.5 million but employs longer peer-review cycles spanning six to nine months. The National Science Foundation emphasizes broader societal impact metrics and frequently requires supplemental educational outreach components.
References
- SBIR/STTR - America's Seed Fund. U.S. Small Business Administration (2025). View source
- SBIR/STTR Program Overview. Congressional Research Service (2025). View source
- SBIR/STTR Apply Guide. SBA (2025). View source
Ready to Explore AI Training?
We help organizations navigate funding programs and deliver claimable AI training. Let us know what you are working on.
Start a Conversation